Recently, we identified CDH1 and CDH13 DNA-methylation in serum samples taken at the time of diagnosis as an independent prognostic marker in cervical cancer patients with no concurrent chemo- or radiation therapy [15]. This evidence concerns the gene CDH1 and cervical carcinoma.